Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next‐Generation Sequencing for Routine Clinical Practice
Clinical and Translational Science · 2026
DOI: 10.1111/cts.70442 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical and Translational Science, 2026. Verfasst von Yaowaluck Hongkaew und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Research and Development, Bumrungrad International Hospital, Bangkok, Thailand. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Pharmacogenomic Testing, Pharmacogenetics. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pharmacogenomics (PGx) is a rapidly evolving field that aims to personalize medicine by identifying genetic variations that influence drug response. While next‐generation sequencing (NGS)–based applications are not yet widely adopted in clinical routine, this study aimed to validate 9 genes of the NGS‐based Ion AmpliSeq Pharmacogenomics Panel on 28 samples with known diplotypes for routine clinical implementation at Bumrungrad International Hospital (BIH). The panel was evaluated for accuracy (> 96.77%), sensitivity (100%), specificity (> 95.31%), positive predictive value (PPV; > 90.63%), negative predictive value (NPV; 100%), and reproducibility (> 99.85%). A novel bioinformatics pipeline, BIH‐protocol, was specifically developed and designed to mitigate errors across all measurement metrics, ensuring reliability and accuracy of test results, even in individuals with complex genetic backgrounds. These results demonstrate 100% precision and reliability of the Ion AmpliSeq Pharmacogenomics Panel together with BIH‐protocol for genetic variation detection. These findings demonstrate the panel's suitability for integration into routine clinical practice and its potential to advance personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Research and Development, Bumrungrad International Hospital, Bangkok, Thailand.
- Laboratory of Clinical Genomics, Bumrungrad International Hospital, Bangkok, Thailand.
- Bumrungrad Genomic Medicine Center, Bumrungrad International Hospital, Bangkok, Thailand.
- Research and Development, Bumrungrad International Hospital, Bangkok, Thailand.
- VitalLife Scientific Wellness Center, Bumrungrad International Hospital, Bangkok, Thailand.
ORCID-Profile: Pattapon Kunadirek, Montinee Sangtian, Srichan Bunlungsup, Tanawat Khunlertkit
Zitieren
APA
Hongkaew, Y., Kunadirek, P., Sangtian, M., Pateetin, P., Bunlungsup, S., Panmontha, W., Kawprasertsri, S., & Khunlertkit, T. (2026). Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next‐Generation Sequencing for Routine Clinical Practice. Clinical and Translational Science. https://doi.org/10.1111/cts.70442
Vancouver
Hongkaew Y, Kunadirek P, Sangtian M, Pateetin P, Bunlungsup S, Panmontha W, et al. Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next‐Generation Sequencing for Routine Clinical Practice. Clinical and Translational Science. 2026. doi:10.1111/cts.70442
BibTeX
@article{Hongkaew2026,
author = {Hongkaew, Yaowaluck and Kunadirek, Pattapon and Sangtian, Montinee and Pateetin, Prangwan and Bunlungsup, Srichan and Panmontha, Wipa and Kawprasertsri, Sornsawan and Khunlertkit, Tanawat},
title = {Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next‐Generation Sequencing for Routine Clinical Practice},
journal = {Clinical and Translational Science},
year = {2026},
doi = {10.1111/cts.70442}
}
EUVIMED